MedPath

石岐制药(广东)有限公司

Ownership
-
Established
2003-12-19
Employees
-
Market Cap
-
Website
www.zhongshanbaoyuan.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

27

NMPA:27

Drug Approvals

Adenosine Disodium Triphosphate Injection

Product Name
三磷酸腺苷二钠注射液
Approval Number
国药准字H44023865
Approval Date
Sep 27, 2020
NMPA

Adenosine Cyclophosphate Injection

Product Name
环磷腺苷注射液
Approval Number
国药准字H20051325
Approval Date
Aug 24, 2020
NMPA

Adenosine Cyclophosphate Injection

Product Name
环磷腺苷注射液
Approval Number
国药准字H20051324
Approval Date
Aug 24, 2020
NMPA

Cefuroxime Sodium for Injection

Product Name
注射用头孢呋辛钠
Approval Number
国药准字H20065033
Approval Date
Aug 24, 2020
NMPA

Hydrochlorothiazide Tablets

Product Name
氢氯噻嗪片
Approval Number
国药准字H44023235
Approval Date
Aug 13, 2020
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H44020604
Approval Date
Apr 27, 2020
NMPA

Compound Aluminium Hydroxide Tablets

Product Name
复方氢氧化铝片
Approval Number
国药准字H44021288
Approval Date
Apr 27, 2020
NMPA

Dexamethasone Sodium Phosphate Injection

Product Name
地塞米松磷酸钠注射液
Approval Number
国药准字H44020602
Approval Date
Mar 17, 2020
NMPA

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H44023869
Approval Date
Mar 13, 2020
NMPA

Compound Vitamin B Tablets

Product Name
复合维生素B片
Approval Number
国药准字H44023274
Approval Date
Mar 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.